![Boris Orlov](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Boris Orlov
Career history of Boris Orlov
Former positions of Boris Orlov
Companies | Position | Start | End |
---|---|---|---|
Innovalve Bio Medical Ltd.
![]() Innovalve Bio Medical Ltd. Medical SpecialtiesHealth Technology Innovalve Bio Medical Ltd. is an Israeli medical device company that specializes in developing catheter-delivered heart valve therapies. Innovalve Bio Medical was founded in 2017 by Boris Orlov and Ehud Raanani, and is currently based in Ramat Gan, IL. The company aims to address the prevalent and progressive disease of Mitral Regurgitation (MR), which affects nearly 1 in 10 people aged 75 and older. MR is a progressive disease that can lead to advanced stages of MR, heart failure, and other complications. Eyal Baror has been the CEO of the company since 2020. | Founder | 01/01/2017 | - |
Lartim Medical Ltd.
![]() Lartim Medical Ltd. Financial ConglomeratesFinance Lartim Medical Ltd. operates as a development stage company. The company was founded by Boris Orlov in 2008 and is headquartered in Kiryat Shmona, Israel. | Director/Board Member | 01/03/2008 | - |
Founder | 27/10/2009 | - |
Statistics
International
Israel | 3 |
Operational
Founder | 2 |
Director/Board Member | 1 |
Sectoral
Finance | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Lartim Medical Ltd.
![]() Lartim Medical Ltd. Financial ConglomeratesFinance Lartim Medical Ltd. operates as a development stage company. The company was founded by Boris Orlov in 2008 and is headquartered in Kiryat Shmona, Israel. | Finance |
Innovalve Bio Medical Ltd.
![]() Innovalve Bio Medical Ltd. Medical SpecialtiesHealth Technology Innovalve Bio Medical Ltd. is an Israeli medical device company that specializes in developing catheter-delivered heart valve therapies. Innovalve Bio Medical was founded in 2017 by Boris Orlov and Ehud Raanani, and is currently based in Ramat Gan, IL. The company aims to address the prevalent and progressive disease of Mitral Regurgitation (MR), which affects nearly 1 in 10 people aged 75 and older. MR is a progressive disease that can lead to advanced stages of MR, heart failure, and other complications. Eyal Baror has been the CEO of the company since 2020. | Health Technology |
- Stock Market
- Insiders
- Boris Orlov
- Experience